Log in or Sign up for Free to view tailored content for your specialty!
Optometry News
BLOG: Opportunities and challenges for digital innovation in medicine
Believe it or not, it’s only been 15 years since the use of electronic health records became common in the U.S.
VIDEO: Begin multifocal contact lens fitting with good refraction
NASHVILLE, Tenn. — Successful multifocal contact lens fitting starts with a good refraction, an industry executive said here at Optometry’s Meeting.
Log in or Sign up for Free to view tailored content for your specialty!
Early data show CAM360 effective for dry eye in 2 days
NASHVILLE, Tenn. — BioTissue’s CAM360 AmnioGraft is showing early success in treating mild to moderate dry eye, according to a company executive here at Optometry’s Meeting.
VIDEO: AI holds ‘lots of opportunity for creative, innovative optometrists’
NASHVILLE, Tenn. — The use of AI in optometry is poised to create new opportunities for eye care providers, according to keynote speaker and leading AI transformation advisor Tom Lawry at Optometry’s Meeting.
VIDEO: Dual Ang-2, VEGF inhibition provides clinical benefits
PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Patricio Schlottmann, MD, discusses dual inhibition of the Ang-2 and VEGF pathways.
Lumify increases short-term tear breakup time in patients with, without dry eye
NASHVILLE, Tenn. — Short-term noninvasive tear breakup time increased with use of Lumify eye drops in cohort of patients with and without dry eye disease, according to a poster presented at Optometry’s Meeting.
FDA grants priority review of NT-501 for macular telangiectasia type 2
The FDA granted priority review of the biologics license application for NT-501 as a treatment for macular telangiectasia type 2, according to a press release from Neurotech Pharmaceuticals.
Preservative-free brimonidine tartrate noninferior to Lumify
NASHVILLE, Tenn. — A preservative-free brimonidine tartrate ophthalmic solution was statistically noninferior to Bausch + Lomb’s Lumify, offering an alternative option for ocular redness relief, according to a poster at Optometry’s Meeting.
VIDEO: Oral treatment shows promise in slowing diabetic retinopathy progression
PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Jay S. Pepose, MD, PhD, of Ocuphire Pharma, discusses an oral small-molecule Ref-1 inhibitor for nonproliferative diabetic retinopathy.
VIDEO: Infuse contact lenses provide growth opportunity for ECPs
NASHVILLE, Tenn. — In this Healio video, William Reindel, OD, shares research that demonstrates a high level of patient satisfaction with Bausch + Lomb’s Infuse contact lenses, providing a practice growth opportunity for eye care providers.
-
Headline News
We must make our voices heard and vote in the 2024 election
September 18, 20247 min read -
Headline News
Semaglutide improves glucose control in automated insulin delivery for type 1 diabetes
September 20, 20243 min read -
Headline News
Oncologists, primary care clinicians should be aware of BRCA testing indications in men
September 19, 20244 min read
-
Headline News
We must make our voices heard and vote in the 2024 election
September 18, 20247 min read -
Headline News
Semaglutide improves glucose control in automated insulin delivery for type 1 diabetes
September 20, 20243 min read -
Headline News
Oncologists, primary care clinicians should be aware of BRCA testing indications in men
September 19, 20244 min read